General Urology

SUNA Supported ANA Catheter-Associated Urinary Tract Infection Prevention Tool

Catheter-associated urinary tract infections (CAUTIs) are the most commonly reported hospital-acquired condition. RNs can play a major role in reducing CAUTI rates. The American Nurses Association (ANA) has developed an innovative, streamlined, evidenced-based clinical tool to aid in reducing CAUTIs. Using a consensus process, ANA assembled a technical expert panel (TEP) of nursing clinical experts to develop and disseminate an evidence-based CAUTI reduction tool for nurses with support by the Partnership for Patients. TEP members included ANA members, representatives from its specialty nursing organizational affiliates, infection control specialists, and patient safety authorities. Diane K. Newman, DNP, FAAN, BCB-PMD, represented SUNA on this panel.

Download the CAUTI Prevention Tool

Download the Background/Guidance Document

More Information

White Paper on Catheter-Associated Urinary Tract Infections

The American Urological Association (AUA) has developed a White Paper on Catheter-Associated Urinary Tract Infections: Definitions and Significance in the Urologic Patient. A white paper workgroup organized by the Quality Improvement and Patient Safety Committee and led by Dr. Timothy Averch drafted the paper, which was approved by the AUA Board of Directors in October 2014. Diane K. Newman, DNP, FAAN, BCB-PMD, represented SUNA on the workgroup.

The workgroup noted that while health care in general has increased its focus on catheter-associated urinary tract infection (CAUTI) prevention and the inappropriate use of catheters, much of this attention does not apply to urologic patients. Therefore, the white paper delves in to this particular area and also provides pertinent definitions pertaining to CAUTIs.

Download the White Paper

 

White Paper on the Incidence, Prevention, and Treatment of Complications Related to Prostate Needle Biopsy

In response to a noted increase in the reports of sepsis and infectious complications after prostate biopsies SUNA and the American Urological Association (AUA) collaborated to draft a white paper. An emerging pattern of fluoroquinolone resistant bacteria, lack of evidence-based, standardized regimen for pre-procedural prophylaxis, and a lack of equipment reprocessing guidelines are addressed in this white paper.

Members of the workgroup included Christopher M. Gonzalez, MD, MBA; Timothy Averch, MD; Lee Ann Boyd, MSN, ARNP, CUNP; J. Quentin Clemens, MD, MSCI; Robert Dowling, MD; Howard B. Goldman, MD; Danil V. Makarov, MD, MHS; Vic Senese, RN; and Mary Anne Wasner, BSN, CURN. Among its summary statements, the workgroup noted the following:

  • The AUA Best Practice Statement on prophylaxis for prostate biopsy indicates fluoroquinolones or 1st-, 2nd-, or 3rd-generation cephalosporins are the antimicrobials of choice. Single-dose regimens appear to be as effective as those spanning 1- or 3-days.
  • Steam sterilization is the preferred method for reprocessing reusable, heat-stable medical devices, including prostate biopsy needle guides; however, high-level disinfection is an acceptable alternative.

Download the White Paper

Pages